» Articles » PMID: 31270965

TERT Gene Polymorphisms Are Associated with Chronic Obstructive Pulmonary Disease Risk in the Chinese Li Population

Overview
Specialty Genetics
Date 2019 Jul 5
PMID 31270965
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide and is characterized by a partially reversible airflow limitation. Currently, many studies put forward that COPD is associated with both genetic and environmental factors. It has been reported that germline mutations in telomerase are risk factors for COPD susceptibility. In this study, we validated the association between TERT polymorphisms and COPD risk with a case-control study in the Chinese Li population.

Methods: A total of 279 COPD patients and 290 control individuals were recruited. We identified five single nucleotide polymorphisms (SNPs) in TERT that were associated with COPD. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated in logistic regression models after adjusting for age and gender to assess the association.

Results: In the genetic model analysis, we found the "C/T-T/T" genotype of rs10069690 in TERT was associated with an increased COPD risk in the dominant model (p = 0.046); the rs2853677 in TERT was significantly associated with increased COPD risk based on the codominant model ("A/G" genotype, p = 0.033), dominant model (A/G-G/G genotype, p = 0.0091), and log-additive model (p = 0.023). The rs2853676 in TERT could increase the risk of COPD in the dominant model ("C/T-T/T" genotype, p = 0.026) and in the Log-additive model (p = 0.022).

Conclusion: Our data shed new light on the association between TERT SNPs and COPD susceptibility in the Chinese Li population.

Citing Articles

Multi-trait and multi-ancestry genetic analysis of comorbid lung diseases and traits improves genetic discovery and polygenic risk prediction.

He Y, Lu W, Jee Y, Wang Y, Tsuo K, Qian D medRxiv. 2024; .

PMID: 39252935 PMC: 11383478. DOI: 10.1101/2024.08.25.24312558.


Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.

Stolz D, Mkorombindo T, Schumann D, Agusti A, Ash S, Bafadhel M Lancet. 2022; 400(10356):921-972.

PMID: 36075255 PMC: 11260396. DOI: 10.1016/S0140-6736(22)01273-9.


Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease.

Choi J, Song J, Rhee C Tuberc Respir Dis (Seoul). 2022; 85(2):122-136.

PMID: 35385639 PMC: 8987660. DOI: 10.4046/trd.2021.0141.


Differential Genomic Profile in , and Between COPD Patients With Emphysema, IPF, and CPFE Syndrome.

Guzman-Vargas J, Ambrocio-Ortiz E, Perez-Rubio G, Ponce-Gallegos M, Hernandez-Zenteno R, Mejia M Front Med (Lausanne). 2021; 8:725144.

PMID: 34490311 PMC: 8416604. DOI: 10.3389/fmed.2021.725144.


Mild catalytic defects of tert rs61748181 polymorphism affect the clinical presentation of chronic obstructive pulmonary disease.

Xu J, de Oliveira D, Trudeau M, Yang Y, Chin J, Sin D Sci Rep. 2021; 11(1):4333.

PMID: 33619289 PMC: 7900122. DOI: 10.1038/s41598-021-83686-z.


References
1.
Kim J, Kang J, Park J, Choi Y, Choi K, Park K . Biological characterization of long-term cultured human mesenchymal stem cells. Arch Pharm Res. 2009; 32(1):117-26. DOI: 10.1007/s12272-009-1125-1. View

2.
Bolton C, Ionescu A, Shiels K, Pettit R, Edwards P, Stone M . Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004; 170(12):1286-93. DOI: 10.1164/rccm.200406-754OC. View

3.
Vogelmeier C, Criner G, Martinez F, Anzueto A, Barnes P, Bourbeau J . Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Respirology. 2017; 22(3):575-601. DOI: 10.1111/resp.13012. View

4.
Manichaikul A, Hoffman E, Smolonska J, Gao W, Cho M, Baumhauer H . Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am J Respir Crit Care Med. 2014; 189(4):408-18. PMC: 3977717. DOI: 10.1164/rccm.201306-1061OC. View

5.
Rabe K, Hurd S, Anzueto A, Barnes P, Buist S, Calverley P . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176(6):532-55. DOI: 10.1164/rccm.200703-456SO. View